Exhibit 10.1
SECURITIES PURCHASE
AGREEMENT
This Securities Purchase Agreement
(this “ Agreement ”) is dated as of
December 10, 2008, between Hecla Mining Company, a Delaware
corporation (the “ Company ”), and each
purchaser identified on the signature pages hereto (each, including
its successors and assigns, a “ Purchaser ” and
collectively the “ Purchasers ”).
WHEREAS, subject to the terms and
conditions set forth in this Agreement and pursuant to an effective
registration statement under the Securities Act of 1933, as amended
(the “ Securities Act ”), the Company desires to
issue and sell to each Purchaser, and each Purchaser, severally and
not jointly, desires to purchase from the Company, securities of
the Company as more fully described in this Agreement.
NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other
good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as
follows:
ARTICLE I.
DEFINITIONS
1.1 Definitions . In addition
to the terms defined elsewhere in this Agreement, for all purposes
of this Agreement, the following terms have the meanings set forth
in this Section 1.1:
“ Acquiring Person
” shall have the meaning ascribed to such in
Section 4.5.
“ Action ” shall
have the meaning ascribed to such term in
Section 3.1(j).
“ Affiliate ”
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under
Rule 405 under the Securities Act.
“ Board of Directors
” means the board of directors of the Company.
“ Business Day ”
means any day except Saturday, Sunday, any day which is a federal
legal holiday in the United States or any day on which banking
institutions in the State of New York are authorized or required by
law or other governmental action to close.
“ Closing ” means
the closing of the purchase and sale of the Securities pursuant to
Section 2.1.
“ Closing Date ”
means the Trading Day when all of the Transaction Documents have
been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers’
obligations to pay the Subscription Amount and (ii) the
Company’s obligations to deliver the Securities have been
satisfied or waived.
“ Commission ”
means the United States Securities and Exchange
Commission.
1
“ Common Stock ”
means the common stock of the Company, par value $0.25 per share,
and any other class of securities into which such securities may
hereafter be reclassified or changed into.
“ Common Stock
Equivalents ” means any securities of the Company or the
Subsidiaries which would entitle the holder thereof to acquire at
any time Common Stock, including, without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for,
or otherwise entitles the holder thereof to receive, Common
Stock.
“ Company Counsel
” means Michael B. White, General Counsel of the Company
and/or Bell, Boyd & Lloyd LLP.
“ Discussion Time
” shall have the meaning ascribed to such term in
Section 3.2(e).
“ Effective Date
” shall mean each date and time that the Registration
Statement, any post-effective amendment or amendments thereto and
any Rule 462(b) Registration Statement became or becomes
effective.
“ Evaluation Date
” shall have the meaning ascribed to such term in
Section 3.1(r).
“ Exchange Act ”
means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder.
“ Exempt Issuance
” means the issuance of (a) shares of Common Stock or
options to former or current employees, officers, directors or
other eligible recipients of the Company pursuant to any stock or
option plan duly adopted for such purpose, by a majority of the
non-employee members of the Board of Directors or a majority of the
members of a committee of non-employee directors established for
such purpose, (b) securities upon the exercise or exchange of
or conversion of any Securities issued hereunder and/or other
securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such
securities or to decrease the exercise, exchange or conversion
price of such securities, (c) securities issued as dividends
on shares of the Company’s 6.5% Mandatory Convertible
Preferred Stock issued and outstanding on the date of this
Agreement, and (d) securities issued pursuant to acquisitions
or strategic transactions approved by a majority of the
disinterested directors of the Company, provided that any such
issuance shall only be to a Person which is, itself or through its
subsidiaries, an operating company in a business synergistic with
the business of the Company or the owner or lessee of real property
or mineral rights which the Company believes are usable in or
related to the Company’s existing lines of business, and in
which the Company receives benefits in addition to the investment
of funds, but shall not include a transaction in which the Company
is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in
securities.
2
“ Final Prospectus
” means the prospectus supplement relating to the Securities
that was first filed pursuant to Rule 424(b) after the
execution of this Agreement, together with the Base Prospectus and
all Commission-filed documents incorporated by reference
therein.
“ Free Writing
Prospectus ” means a free writing prospectus, as defined
in Rule 405.
“ FWS ” means
Feldman Weinstein & Smith LLP with offices located at 420
Lexington Avenue, Suite 2620, New York, New York
10170-0002.
“ Issuer Free Writing
Prospectus ” means an issuer free writing prospectus, as
defined in Rule 433.
“ knowledge of the
Company ” means the actual knowledge of an executive
officer of the Company.
“ Material Adverse
Effect ” means any event that (i) would reasonably
be expected to have a material adverse effect on the performance of
this Agreement or the consummation of any of the transactions
contemplated hereby or (ii) would reasonably be expected to
have a material adverse effect on the condition (financial or
otherwise), business prospects, earnings, business or properties of
the Company and its subsidiaries, taken as a whole, whether or not
arising from transactions in the ordinary course of
business.
“ Material Permits
” shall have the meaning ascribed to such term in
Section 3.1(m).
“ Per Share Purchase
Price ” equals $2.05, subject to appropriate adjustment
for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock
that occur after the date of this Agreement.
“ Person ” means
an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or
subdivision thereof) or other entity of any kind.
“ Placement Agent
” means Rodman & Renshaw, LLC.
“ Preliminary
Prospectus ” means any preliminary prospectus supplement
to the Base Prospectus, which is used prior to the filing of the
Final Prospectus, together with the Base Prospectus.
“ Proceeding ”
means an action, claim, suit, investigation or proceeding
(including, without limitation, an informal investigation or
partial proceeding, such as a deposition), whether commenced or
overtly threatened.
“ Prospectus ”
means the final prospectus filed for the Registration
Statement.
3
“ Prospectus Supplement
” means the supplement to the Prospectus complying with Rule
424(b) of the Securities Act that is filed with the Commission and
delivered by the Company to each Purchaser at the
Closing.
“ Purchaser Party
” shall have the meaning ascribed to such term in
Section 4.8.
“ Registration
Statement ” means the effective registration statement
with Commission file No. 333-145919 which registers the sale
of the Shares, the Warrants and the Warrant Shares by the
Purchasers.
“ Rule 144 ”
means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.
“ SEC Reports ”
shall have the meaning ascribed to such term in
Section 3.1(h).
“ Securities ”
means the Shares, the Warrants and the Warrant Shares.
“ Securities Act
” means the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder.
“ Shares ” means
the shares of Common Stock issued or issuable to each Purchaser
pursuant to this Agreement.
“ Short Sales ”
means all “short sales” as defined in Rule 200 of
Regulation SHO under the Exchange Act (but shall not be deemed to
include the location and/or reservation of borrowable shares of
Common Stock).
“ Significant
Subsidiary ” means each significant subsidiary of the
Company as defined by Rule 1-02 of Regulation S-X.
“ Subscription Amount
” means, as to each Purchaser, the aggregate amount to be
paid for Shares and Warrants purchased hereunder as specified below
such Purchaser’s name on the signature page of this Agreement
and next to the heading “Subscription Amount,” in
United States dollars and in immediately available
funds.
“ Subsidiary ”
means any subsidiary of the Company as set forth in the
Registration Statement and shall, where applicable, also include
any direct or indirect subsidiary of the Company formed or acquired
after the date hereof.
“ Trading Day ”
means a day on which the New York Stock Exchange is open for
trading.
“ Trading Market
” means the New York Stock Exchange.
4
“ Transaction Documents
” means this Agreement, the Warrants and any other documents
or agreements executed in connection with the transactions
contemplated hereunder.
“ Transfer
Agent ” means American Stock Transfer & Trust
Company, the current transfer agent of the Company, with a mailing
address of 6201 15 th Avenue, 3
rd
Floor, Brooklyn, NY
11219 and a facsimile number of 718-921-8327, and any successor
transfer agent of the Company.
“ Variable Rate
Transaction ” shall have the meaning ascribed to such
term in Section 4.11(b).
“
Warrants ” means, collectively, the Series 1 Common
Stock purchase warrants (the “ Series 1 Warrants
”) delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Warrants shall be
exercisable on the 181 st day following the date of
issuance and have a term of exercise equal to 5 years, in the form
of Exhibit A-1 attached hereto, and the Series 2 Common
Stock purchase warrants (the “ Series 2 Warrants
”) delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Warrants shall be
exercisable on the date of issuance and have a term of exercise
expiring February 28, 2009, in the form of Exhibit A-2
attached hereto.
“ Warrant Shares
” means the shares of Common Stock issuable upon exercise of
the Warrants.
ARTICLE II.
PURCHASE AND SALE
2.1 Closing. On the Closing
Date , upon the terms and subject to the conditions set forth
herein, substantially concurrent with the execution and delivery of
this Agreement by the parties hereto, the Company agrees to sell,
and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of 10,243,902 of Shares and 7,682,927 Series 1
Warrants and 7,682,927 Series 2 Warrants; provided ,
however , that such securities shall not be issued until the
earlier of (i) compliance with the covenant set forth in
Section 4.9 and (ii) December 15, 2008. Each
Purchaser shall deliver to the Company, via wire transfer,
immediately available funds equal to its Subscription Amount and
the Company shall deliver to each Purchaser its respective Shares
and Warrants as determined pursuant to Section 2.2(a), and the
Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3,
the Closing shall occur at the offices of FWS or such other
location as the parties shall mutually agree.
2.2 Deliveries .
(a) On or prior to the Closing Date,
the Company shall deliver or cause to be delivered to each
Purchaser the following:
(i) this Agreement duly executed by
the Company;
5
(ii) a legal opinion of Company
Counsel, substantially in the form of Exhibit B attached
hereto;
(iii) a copy of the irrevocable
instructions to the Company’s transfer agent instructing the
transfer agent to deliver via the Depository Trust Company Deposit
Withdrawal Agent Commission System (“ DWAC ”)
the Shares registered in the name of such Purchaser;
(iv) a Series 1 Warrant registered
in the name of such Purchaser to purchase up to a number of shares
of Common Stock equal to 75% of the number of Shares purchased by
such Purchaser, with an exercise price equal to $2.45, subject to
adjustment therein (such Warrant certificate may be delivered
within three Trading Days of the Closing Date);
(v) a Series 2 Warrant registered in
the name of such Purchaser to purchase up to a number of shares of
Common Stock equal to 75% of the number of Shares purchased by such
Purchaser, with an exercise price equal to $2.35, subject to
adjustment therein (such Warrant certificate may be delivered
within three Trading Days of the Closing Date); and
(vi) the Prospectus and Prospectus
Supplement (which may be delivered in accordance with Rule 172
under the Securities Act).
(b) On or prior to the Closing Date,
each Purchaser shall deliver or cause to be delivered to the
Company the following:
(i) this Agreement duly executed by
such Purchaser; and
(ii) such Purchaser’s
Subscription Amount by wire transfer to the account as specified in
writing by the Company.
2.3 Closing Conditions
.
(a) The obligations of the Company
hereunder in connection with the Closing are subject to the
following conditions being met:
(i) the accuracy in all material
respects on the Closing Date of the representations and warranties
of the Purchasers contained herein (unless as of a specific date
therein);
(ii) all obligations, covenants and
agreements of each Purchaser required to be performed at or prior
to the Closing Date shall have been performed; and
(iii) the delivery by each Purchaser
of the items set forth in Section 2.2(b) of this
Agreement.
6
(b) The respective obligations of
the Purchasers hereunder in connection with the Closing are subject
to the following conditions being met:
(i) the accuracy in all material
respects on the Closing Date of the representations and warranties
of the Company contained herein (unless as of a specific date
therein);
(ii) all obligations, covenants and
agreements of the Company required to be performed at or prior to
the Closing Date shall have been performed;
(iii) the delivery by the Company of
the items set forth in Section 2.2(a) of this
Agreement;
(iv) the approval of the Listing of
Additional Shares application by The New York Stock Exchange upon
notice of issuance
(v) there shall have been no
Material Adverse Effect with respect to the Company since the date
hereof; and
(vi) from the date hereof to the
Closing Date, trading in the Common Stock shall not have been
suspended by the Commission or the Company’s principal
Trading Market (except for any suspension of trading of limited
duration agreed to by the Company, which suspension shall be
terminated prior to the Closing), and, at any time prior to the
Closing Date, trading in securities generally as reported by
Bloomberg L.P. shall not have been suspended or limited, or minimum
prices shall not have been established on securities whose trades
are reported by such service, or on any Trading Market, nor shall a
banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any
material outbreak or escalation of hostilities or other national or
international calamity of such magnitude in its effect on, or any
material adverse change in, any financial market which, in each
case, in the reasonable judgment of each Purchaser, makes it
impracticable or inadvisable to purchase the Securities at the
Closing.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES
3.1 Representations and
Warranties of the Company . Except as set forth in the Final
Prospectus, which Final Prospectus shall qualify any representation
or otherwise made herein to the extent of the disclosure contained
in the Final Prospectus, the Company hereby makes the following
representations and warranties to each Purchaser:
(a) SEC Reports; Financial
Statements . The Company has filed all reports, schedules,
forms, statements and other documents required to be filed by the
Company under the Securities Act and the Exchange Act, including
pursuant to Section 13(a) or 15(d) thereof, for the two years
preceding the date hereof (or such shorter period as the Company
was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents
incorporated by reference therein,
7
together with the Final Prospectus,
being collectively referred to herein as the “ SEC
Reports ”) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading.
(b) Registration . The
Company meets the requirements for use of Form S-3ASR under
the Act and has prepared and filed with the Commission an automatic
shelf registration statement (file number 333-145919) on
Form S-3ASR, including a related base prospectus, for
registration under the Act of the offering and sale of the
Securities. Such Registration Statement, including any amendments
thereto filed prior to the date hereof has become effective. The
Company may have filed with the Commission, with the Registration
Statement or pursuant to Rule 424(b), one or more preliminary
prospectus supplements relating to the Securities, each of which
has previously been furnished to you. The Company will file with
the Commission a final prospectus supplement relating to the
Securities in accordance with Rule 424(b). As filed, such
final prospectus supplement shall contain all information required
by the Act and the rules thereunder, and, except to the extent the
Placement Agent shall agree in writing to a modification, shall be
in all substantive respects in the form furnished to you prior to
the execution hereof or, to the extent not completed prior to the
execution hereof, shall contain only such specific additional
information and other changes (beyond that contained in the Base
Prospectus and any Preliminary Prospectus) as the Company has
advised you, prior to the execution hereof, will be included or
made therein. The Registration Statement, as of the date hereof,
meets the requirements set forth in
Rule 415(a)(1)(x).
(c) Accuracy of Registration
Statement . On the Effective Date, the Registration Statement
did, and when the Final Prospectus is first filed in accordance
with Rule 424(b) and on the Closing Date (as defined
herein), the Final Prospectus (and any supplement thereto) will,
comply in all material respects with the applicable requirements of
the Securities Act and the Exchange Act and the respective rules
thereunder; on the Effective Date and at the date hereof, the
Registration Statement did not and will not contain any untrue
statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the
statements therein not misleading; and on the date of any filing
pursuant to Rule 424(b) and on the Closing Date, the
Final Prospectus (together with any supplement thereto) will not
include any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading; provided, however, that the Company makes no
representations or warranties as to the information contained in or
omitted from the Registration Statement or the Final Prospectus (or
any supplement thereto) in reliance upon and in conformity with
information furnished in writing to the Company by or on behalf of
the Placement Agent specifically for inclusion in the Registration
Statement or the Final Prospectus (or any supplement thereto), it
being understood and agreed that the only such information
furnished by or on behalf of the Placement Agent consists of the
information in the “Plan of Distribution” of the
Prospectus Supplement.
8
(d) Intentionally
Omitted.
(e) WKSI Eligibility .
(a) At the time of filing the Registration Statement, and
(b) at the time of the most recent amendment thereto for the
purposes of complying with Section 10(a)(3) of the Act
(whether such amendment was by post-effective amendment,
incorporated report filed pursuant to Sections 13 or 15(d) of the
Exchange Act or form of prospectus), the Company was a “well
known seasoned issuer” as defined in Rule 405, including
not having been an “ineligible issuer” as defined in
Rule 405. At the earliest time after the filing of the
Registration Statement that the Company or another offering
participant made a bona fide offer (within the meaning of
Rule 164(h)(2) of the Act) of any Securities and at the time that
this Agreement is executed and delivered by the parties hereto, the
Company was not an “ineligible issuer” (as defined in
Rule 405) as of the eligibility determination date for purpose
of Rule 164 and 433 under the Act with respect to the offering
of the Securities contemplated hereby.
(f) Free Writing Prospectuses
. No Issuer Free Writing Prospectus includes any information that
conflicts with the information contained in the Registration
Statement, including any document incorporated by reference therein
and any prospectus supplement deemed to be a part thereof that has
not been superseded or modified. The foregoing sentence does not
apply to statements in or omissions from any Issuer Free Writing
Prospectus based upon and in conformity with written information
furnished to the Company by the Placement Agent specifically for
use therein, it being understood that the only such information
furnished by or on behalf of the Placement Agent is contained in
the “Plan of Distribution” section of the Prospectus
Supplement.
(g) Due Incorporation . Each
of the Company and its material domestic Subsidiaries has been duly
incorporated and is validly existing as a corporation in good
standing under the laws of the jurisdiction in which it is
chartered or organized with full corporate power and authority to
own or lease, as the case may be, and to operate its properties and
conduct its business as described in the Final Prospectus, and is
duly qualified to do business as a foreign corporation and is in
good standing under the laws of each jurisdiction which requires
such qualification, except where the failure to qualify would not
have a Material Adverse Effect.
(h) Subsidiaries . All the
outstanding shares of capital stock of each subsidiary of the
Company have been duly and validly authorized and issued and are
fully paid and nonassessable, and all outstanding shares of capital
stock of the Company’s Subsidiaries (other than qualifying
shares for foreign Subsidiaries) are owned by the Company either
directly or through wholly owned subsidiaries free and clear of any
security interests, claims, liens or encumbrances, except for the
interests of Hecla Alaska LLC, Hecla Limited, Hecla Admiralty
Company, Hecla Greens Creek Mining Company, Hecla Juneau Mining
Company, Burke Trading, Inc. and Hecla Mining Company of Canada
Ltd. that have been pledged on a term facility and a bridge
facility pursuant to an amended and restated credit agreement,
dated as of April 16, 2008, among the Company, the various
Lenders named therein, The Bank of Nova Scotia and Scotia Capital
(the “Credit Agreement”), as disclosed in the Final
Prospectus.
9
(i) Capitalization . The
Company’s authorized equity capitalization is as set forth in
the Final Prospectus. The share capital of the Company conforms in
all material respects to the description thereof contained in the
Final Prospectus. The outstanding shares of capital stock have been
duly and validly authorized and issued and are fully paid and
nonassessable. The holders of outstanding shares of capital stock
of the Company are not entitled to preemptive or other rights to
subscribe for the Securities; and except as set forth in the Final
Prospectus or subsequent issuance, if any, pursuant to this
Agreement, pursuant to reservations, agreements or employee benefit
plans referred to in the Final Prospectus or pursuant to the
exercise of convertible securities or options referred to in the
Final Prospectus, no options, warrants or other rights to purchase,
agreements or other obligations to issue, or rights to convert any
obligations into or exchange any securities for, shares of capital
stock of or ownership interests in the Company are outstanding as
of the date of the information set forth in the Final Prospectus in
respect of the capitalization of the Company.
(j) Due Authorization . This
Agreement has been duly authorized, executed and delivered by the
Company.
(k) Validity of Securities .
The Securities being sold hereunder by the Company have been duly
and validly authorized, and, when issued and delivered to and paid
for by the Purchasers pursuant to this Agreement, will be fully
paid and nonassessable and conform in all material respects with
the description of the Securities set forth in the Final
Prospectus. The certificates for the Securities are in valid and
sufficient form.
(l) No Adverse Events .
Neither the Company nor any of its subsidiaries has sustained since
the date of the latest audited financial statements included or
incorporated by reference in the Final Prospectus any material loss
or interference with its business from fire, explosion, flood or
other calamity, whether or not covered by insurance, or from any
labor dispute or court or governmental action, order or decree,
material to the Company taken as a whole, otherwise than as set
forth or contemplated in the Final Prospectus; and, since the
respective dates as of which information is given in the Final
Prospectus, there has not been any change in the capital stock
(other than employee benefit plan issuances or conversion of
outstanding securities of the Company) or long-term debt of the
Company or any of its subsidiaries or any material adverse change,
in or affecting the general affairs, management, financial
position, stockholders’ equity or results of operations of
the Company and its subsidiaries, except as set forth in the Final
Prospectus.
(m) Material Contracts .
There is no franchise, contract or other document of a character
required to be described in the Registration Statement, the SEC
Reports or the Final Prospectus, or to be filed as an exhibit
thereto, which is not described or filed as required.
10
(n) Investment Company . The
Company is not and, after giving effect to the offering and sale of
the Securities and the application of the proceeds thereof as
described in the Final Prospectus, will not be an “investment
company” as defined in the Investment Company Act of 1940, as
amended.
(o) Regulatory Approvals . No
consent, approval, authorization, filing with or order of any court
or governmental agency or body is required in connection with the
transactions contemplated herein, except (1) such as have been
obtained or may be required under the Act, (2) such as may be
required by the Financial Industry Regulatory Authority and the New
York Stock Exchange, and (3) such as may be required under the
blue sky laws of any jurisdiction in connection with the purchase
and distribution of the Securities by the Placement Agent in the
manner contemplated herein and in the Final Prospectus and such as
may be required with the securities regulatory authorities in each
of the Canadian Jurisdictions.
(p) No Conflicts . Other than
breaches, conflicts, violations and encumbrances which singly or in
the aggregate are not reasonably expected to have a Material
Adverse Effect under clauses (ii), (iii) and (iv) below,
none of the issue and sale of the Securities, the execution and
delivery by the Company of this Agreement and the consummation of
any other of the transactions herein contemplated nor the
fulfillment of the terms hereof will conflict with, result in a
breach or violation of, or result in the imposition of any lien,
charge or encumbrance upon any property or assets of the Company or
any of its subsidiaries pursuant to: (i) the organizational
documents of the Company or any of its subsidiaries, (ii) the
terms of any indenture, contract, lease, mortgage, deed of trust,
note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which the Company or any of
its subsidiaries is a party or bound or to which its or their
property is subject, (iii) any statute, law, rule, or
regulation, or (iv) any judgment, writ, injunction, ruling,
order or decree of any court, regulatory body, administrative
agency, governmental body, arbitrator or other authority having
jurisdiction over the Company or any of its subsidiaries or any of
its or their properties.
(q) Financial Statements .
The consolidated historical financial statements of the Company and
its subsidiaries and the Greens Creek Joint Venture included or
incorporated by reference in the Final Prospectus present fairly in
all material respects the consolidated financial condition, results
of operations and cash flows of the Company and its subsidiaries as
of the dates and for the periods indicated, comply as to form with
the applicable accounting requirements of the Securities Act and
the Exchange Act and have been prepared in conformity with United
States generally accepted accounting principles applied on a
consistent basis throughout the periods involved (except as
otherwise noted therein). The summary financial information
included in the Final Prospectus present fairly in all material
respects the information shown therein and have been compiled on a
basis consistent with that of the audited financial statements
included in the Registration Statement. The pro forma financial
statements and the related notes thereto included or incorporated
by reference in the Final Prospectus present fairly in all material
respects the information shown therein, have been prepared in
accordance with the Commission’s rules and guidelines with
respect to pro forma financial statements and have been properly
compiled on the bases described therein, and the assumptions used
in
11
the preparation thereof are
reasonable and the adjustments used therein are appropriate to give
effect to the transactions and circumstances referred to therein.
All disclosures contained in the Final Prospectus regarding
“non-GAAP financial measures” (as such term is defined
by the rules and regulations of the Commission) comply with
Regulation G under the Exchange Act and Item 10 of Regulation
S-K promulgated under the Securities Act, to the extent
applicable.
(r) No Litigation . No
action, suit or proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries or its or their property is pending or,
to the knowledge of the Company, overtly threatened that are
reasonably expected to have a Material Adverse Effect, except as
set forth in the Final Prospectus (exclusive of any supplements
thereto).
(s) Title to Assets . Each of
the Company and each of its Significant Subsidiaries owns or leases
all such properties as are necessary to the conduct of its
operations as presently conducted; the Company and its Significant
Subsidiaries have good and marketable title to all real property
owned by them, and good and marketable title to all personal
property owned by them, in each case free and clear of all liens,
encumbrances and defects except as set forth in the Final
Prospectus or such as do not materially affect the value of such
property and do not interfere with the use made and proposed to be
made of such property by the Company and its Significant
Subsidiaries; and any real property and buildings held under lease
by the Company and its Significant Subsidiaries are held by them
under valid, subsisting and enforceable leases with such exceptions
as are not material and do not interfere with the use made and
proposed to be made of such property and buildings by the Company
and its Significant Subsidiaries.
(t) No Default . Neither the
Company nor any subsidiary of the Company is in violation or
default of (1) any provision of its organizational documents,
(2) the terms of any indenture, contract, lease, mortgage,
deed of trust, note agreement, loan agreement or other agreement,
obligation, condition, covenant or instrument to which it is a
party or bound or to which its property is subject, or (3) any
statute, law, rule, regulation, judgment, order or decree of any
court, regulatory body, administrative agency, governmental body,
arbitrator or other authority having jurisdiction over the Company
or such subsidiary or any of its properties, as applicable, any of
which defaults or violations described in clauses (2) through
(3) will have, or after any required notice and passage of any
applicable grace period, is reasonably expected to have a Material
Adverse Effect.
(u) Accountants . Each of BDO
Seidman, LLP and PricewaterhouseCoopers LLP, who have audited
certain financial statements of the Company and its consolidated
subsidiaries and delivered their report with respect to the audited
consolidated financial statements and schedules included or
incorporated by reference in the Final Prospectus, is an
independent registered public accounting firm with respect to the
Company within the meaning of the Securities Act and the Exchange
Act and the applicable published rules and regulations
thereunder.
(v) Taxes . Except as
described in the Final Prospectus and except as would not singly or
in the aggregate reasonably be expected to result in a Material
Adverse Effect,
12
the Company has filed all foreign,
federal, state and local tax returns that are required to be filed
or has requested extensions thereof, and has paid all taxes
required to be paid by it and any other assessment, fine or penalty
levied against it, to the extent that any of the foregoing is due
and payable, except for any such assessment, fine or penalty that
is currently being contested in good faith.
(w) Labor Relations . Except
as described in the SEC Reports and the Registration Statement, no
labor problem or dispute with the employees of the Company or any
of its Significant Subsidiaries exists or to the knowledge of the
Company is overtly threatened or imminent, and the Company is not
aware of any existing or imminent labor disturbance by the
employees of any of its or its Significant Subsidiaries’
principal suppliers, contractors or customers, that is reasonably
expected to result in a Material Adverse Effect.
(x) Insurance . The Company
and each of its Significant Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses
in which they are engaged; all policies of insurance and fidelity
or surety bonds insuring the Company or any of its Significant
Subsidiaries or their respective businesses, assets, employees,
officers and directors are in full force and effect, except where
the failure to be in full force and effect would not, singly or in
the aggregate, reasonably be expected to result in a Material
Adverse Effect; the Company and its Significant Subsidiaries are in
compliance with the terms of such policies and instruments in all
material respects; and except as described in the Final Prospectus
and except as would not, singly or in the aggregate, reasonably be
expected to result in a Material Adverse Effect, there are no
claims by the Company or any of its subsidiaries under any such
policy or instrument as to which any insurance company is denying
liability or defending under a reservation of rights clause;
neither the Company nor any such Significant Subsidiary has been
refused any insurance coverage sought or applied for; and neither
the Company nor any such Significant Subsidiary has any reason to
believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its
business at a cost that is not reasonably expected to have a
Material Adverse Effect.
(y) Rights in Subsidiaries .
No subsidiary of the Company is currently prohibited, directly or
indirectly, from paying any dividends to the Company, from making
any other distribution on such subsidiary’s capital stock,
from repaying to the Company any loans or advances to such
subsidiary from the Company or, except as prohibited by the Credit
Agreement and as disclosed in the Final Prospectus, from
transferring any of such subsidiary’s property or assets to
the Company or any other subsidiary of the Company.
(z) Permits etc. The Company
and its subsidiaries possess all licenses, concessions,
certificates, permits and other authorizations issued by the
appropriate federal, state or foreign regulatory authorities
necessary to conduct their respective businesses
(“Permits”); the Company and its subsidiaries have
fulfilled and performed in all material respects all of their
respective obligations with respect to such Permits and neither the
Company nor any such subsidiary has received any notice of
proceedings
13
relating to the revocation or
modification of any such Permit which, singly or in the aggregate,
is reasonably expected to have a Material Adverse Effect, except as
set forth in the Final Prospectus (exclusive of any supplement
thereto).
(aa) Internal Controls . The
Company and each of its subsidiaries maintains and will maintain a
system of internal accounting controls sufficient to provide
reasonable assurance that (1) transactions are executed in
accordance with management’s general or specific
authorizations; (2) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
United States generally accepted accounting principles